Scientific Program

Conference Series Ltd invites all the participants across the globe to attend International Conference on Maternal, Fetal and Neonatal Medicine Istanbul, Turkey.

Day 1 :

Keynote Forum

Brankica Vasiljevic

NMC Royal Hospital, UAE

Keynote: Stem cell based therapy in neonates

Time : 10:00-11:00

Conference Series Fetal Medicine 2019 International Conference Keynote Speaker Brankica Vasiljevic photo
Biography:

Brankica Vasiljevic is currently working as the Head of Maternity and Child Health Services in NMC Royal Hospital DIP in Dubai, UAE. She had completed her Clinical Post-graduation Education and Academic Post-graduate Education (MSc in pediatric and ultrasonography field and PhD in neonatology field) at Belgrade University School of Medicine in Belgrade, Serbia. She has published more than 35 international publications in international indexed journals (100 citations), 5 chapters in various fields of Neonatal Medicine and has more than 30 presentations in international conferences.

Abstract:

Despite recent advances in neonatal intensive therapy, still is present significant morbidity associated with extreme prematurity that includes both short-term and long-term pulmonary, neurologic and visual impairments. These complications of prematurity not only affect the quality of life of these children in the rest of their lives, but can also cause numerous medical and economic burdens in the society. No single therapy has proven to be effective in preventing or treating developmental lung, brain and retinal injuries in preterm infants or the hypoxic-ischemic brain injury in full-term infants. Stem cell based therapies are emerging as potential alternative treatment for such complex diseases (BPD, IVH, ROP and HIE) with multifactorial etiologies. Recently, various preclinical studies have shown that stem cell therapy significantly attenuates injuries in newborn animal models of BPD, HIE, IVH and ROP. Caution is warranted, however because stem cell-based therapies for regenerative purposes represent innovation, mechanisms of action are still not completely understood and standardization, clinical indications, timing and dosage are required to permit safe clinical translation of stem cell therapy in animal models for newborn infants in the near future.

Break: 11:00-11:30 Networking and Refreshments Break with Group Photo

Keynote Forum

Aziz Koleilat

Makassed University General Hospital, Lebanon

Keynote: The brain and microbial flora: Role of gut microbiota in the gut-brain axis

Time : 11:30-12:30

Conference Series Fetal Medicine 2019 International Conference Keynote Speaker Aziz Koleilat photo
Biography:

Aziz Koleilat is currently working as a Vice General Secretary, Pashan Pan Arab Society Pediatric Gastroenterology Hepatology and Senior Pediatric Consultant Gastroenterology and also Asthma IBR Member Makassed General Hospital, Lebanon.

Abstract:

The human gut host 1014 bacterial organisms, an amount that exceeds the cells within the body. Microbiota is the bacteria living both inside and on the human body (a community collectively known as, dwelling in the human microbiome) mostly are friendly; outnumber the somatic and germ cells of the body by a factor of 10. Specific to the human gut is the commensal microflora, enters into an important symbiotic association with the human host beginning with the colonization of the Gastrointestinal (GI) tract by the bacteria within half an hour after delivery and continue to develop depending on many factors, this is developmental process begins at birth, continues through early development and remains for life. This developmental processing is actually acted during vulnerable or sensitive developmental periods and thus exerts influences that impact on the structure and function of organs (brain) that last throughout life. However, although the colonization of microbiota is due to postnatal environmental factors and is also affected by genetics, it is consistent and is difficult to change after reaching the adult form. It has a pre and post natal effect on developing infant brain. The microbiota is essential to the proper development of the mucosal and systemic immune systems and in nutrient uptake and metabolism as an important contributor in making the individual’s physiology and influence the function of the central nervous system (CNS) and behavior. Of particular interest is the impact on the functional development of the infant (mammalian) brain. The developing brain is susceptible to internal and external cues during its perinatal life, an important point when considering the association between common neurodevelopmental disorders (e.g. autism, schizophrenia) and microbial pathogen infections during this same period. Breast feeding and probiotics now being recognized in the brain–gut axis interactions.

Break: Lunch Break 12:30-13:30 @ Restaurant